Radiofrequency Ablation
FDA approves several radiofrequency AF ablation catheters for use without fluoroscopy
Biosense Webster announced several of its products in its cardiac ablation portfolio have received FDA approval for use without fluoroscopy.
Minimally invasive procedure enhances care for periacetabular osteolytic metastasis
Massive osteolytic metastases in the periacetabular regions are clinical dilemmas.
FAST AND FURIOUS PVI
Very high-power, short-duration ablation for PVI utilizing a novel catheter with a very close protocol vs. conventional contact force sensing AI-guided radiofrequency ablation.
EARLY
Assessing atrial fibrillation recurrence post-ablation after administration of IV adenosine.
Novel catheter meets primary endpoints in trial of treatment for right atrial flutter
A trial of a gold-tipped contact force-sensing catheter for treatment of patients with atrial flutter met its primary endpoints, researchers reported at AF Symposium.
Novel radiofrequency catheter achieves performance goals in patients with AF
A novel multielectrode radiofrequency balloon catheter achieved its safety and effectiveness performance goals in the STELLAR investigational device exemption study, researchers reported at the AF Symposium.
Q&A: Non-invasive scan facilitates detection and cure of common hypertension cause
A novel CT scan helped physicians identify hormone-producing nodules that cause hypertension, curing some patients of the condition with their removal, according to the results of a prospective, within-patient trial.
Early adenosine dose after ablation may help predict accessory pathway conduction
An IV bolus of adenosine administered 10 minutes after radiofrequency ablation of the accessory pathway has the same diagnostic accuracy as waiting 30 minutes for predicting the resumption of pathway conduction, researchers reported.
Novel very high-power short-duration ablation for pulmonary vein isolation ‘safe, effective’
A novel catheter for very high-power short-duration ablation for pulmonary vein isolation reduced procedure time with similar atrial fibrillation/atrial tachycardia recurrence at 1 year vs. standard ablation, researchers reported.
Similar safety, efficacy with 90 W vs. 50 W radiofrequency ablation for AF
Very high-powered short-duration radiofrequency ablation for atrial fibrillation with 90 W using a next-generation catheter was safe and effective vs. high-powered short-duration 50 W radiofrequency ablation, researchers reported.